New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Dynavax Technologies Corporation
DVAX
Shape
US Flag

NASDAQ

EPS improving

EPS improving

1B

Drug Manufacturers - Specialty & Generic

Next Earning date - 07 Nov 2024

1B

Drug Manufacturers - Specialty & Generic

Next Earning date - 07 Nov 2024

11.39USD
Shape0.68 ( 6.35%)
favorite-chart

Relative Strenght

27
favorite-chart

Volume Buzz

45%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

25%

Quote Panel

Shape
Updated October 28, 2024
1W 3.73 % 1M 2.33 % 3M -1.47 % 1Y -21.16 %

Key Metrics

Shape
  • Market Cap

    1.49B


  • Shares Outstanding

    131.04M


  • Share in Float

    130.41M


  • Dividende

    0


  • Earning Date

    07 Nov 2024


  • Price Target

    11.39


  • Average Volume

    2.08M


  • Beta

    1.369


  • Range

    9.74-15.15


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.dynavax.com


  • Sector

    Healthcare


Fundamentals

Shape

102.11x

P/E Ratio

5.96x

P/S Ratio

2.31x

P/B Ratio

0.4

Debt/Equity

6.9%

Net Margin

$0.1

EPS

How DVAX compares to sector?

P/E Ratio

Relative Strength

Shape

DVAX

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$338M

Shape358%

2025-Revenue

$0.39

Shape348%

2025-EPS

$79M

Shape-1087%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

JMP Securities

initialise

Previous: Not converted

2022-09-27

Now: Outperform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+617%

0.43
vs 0.06

Q4.22

arrow
arrow

-15%

0.45
vs 0.53

Q1.23

arrow
arrow

N/A

-0.19
vs 0.22

Q2.23

arrow
arrow

-97%

0.03
vs 0.87

Q3.23

arrow
arrow

-77%

0.1
vs 0.43

Q4.23

arrow
arrow

-100%

0
vs 0.45

Q1.24

arrow
arrow

N/A

-0.07
vs -0.19

Q2.24

arrow
arrow

+167%

0.08
vs 0.03

Q3.24

arrow
arrow

+13%

0.11
vs 0.1

Q4.24

arrow
arrow

+2385%

0.04
vs 0

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+55%

167.7M  vs 108.3M

Q4.22

arrow
arrow

-5%

184.5M  vs 195.1M

Q1.23

arrow
arrow

-59%

46.9M  vs 114M

Q2.23

arrow
arrow

-77%

60.2M  vs 256.5M

Q3.23

arrow
arrow

-59%

69.5M  vs 167.7M

Q4.23

arrow
arrow

-70%

55.6M  vs 184.5M

Q1.24

arrow
arrow

+8%

50.8M  vs 46.9M

Q2.24

arrow
arrow

+22%

73.8M  vs 60.2M

Q3.24

arrow
arrow

+21%

84.2M  vs 69.5M

Q4.24

arrow
arrow

+30%

72.4M  vs 55.6M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

+13%

0.13
vs 0.3

Q4.22

arrow
arrow

+12%

0.12
vs 0.13

Q1.23

arrow
arrow

-4%

-0.04
vs 0.12

Q2.23

arrow
arrow

+1%

0.01
vs -0.04

Q3.23

arrow
arrow

+2%

0.02
vs 0.01

Q4.23

arrow
arrow

+0%

0
vs 0.02

Q1.24

arrow
arrow

-1%

-0.01
vs 0

Q2.24

arrow
arrow

+2%

0.02
vs -0.01

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

244

244
vs 220

11%

Q4.22

arrow
arrow

240

240
vs 244

-2%

Q1.23

arrow
arrow

215

215
vs 240

-10%

Q2.23

arrow
arrow

217

217
vs 215

1%

Q3.23

arrow
arrow

230

230
vs 217

6%

Q4.23

arrow
arrow

246

246
vs 230

7%

Q1.24

arrow
arrow

256

256
vs 246

4%

Q2.24

arrow
arrow

243

243
vs 256

-5%

Earnings Growth

Latest News

DVAX

seekingalpha.com

12 hours ago